SWMG
NVAX icon

Strategic Wealth Management Group’s Novavax NVAX Stock Holding History

Strategic Wealth Management Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,221
Closed -$2.4M – 131
2021
Q1 		$2.4M Sell
13,221
-157
-1% -$31.3K 0.92% 16
2020
Q4 		$1.49M Buy
13,378
+5,812
+77% +$618K 0.65% 25
2020
Q3 		$820K Buy
7,566
+37
+0.5% +$4.51K 0.4% 37
2020
Q2 		$628K Buy
+7,529
New +$288K 0.37% 39

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Strategic Wealth Management Group's NVAX Position: Q2 2021 in Review

Strategic Wealth Management Group sold out of Novavax (NVAX) in Q2 2021, closing a stake of 13,221 shares — an estimated $2.4M sold.

Strategic Wealth Management Group first reported a position in NVAX in Q2 2020 and held it in 4 quarters. The position peaked at $2.4M in Q1 2021. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

  • Strategic Wealth Management Group reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
  • Strategic Wealth Management Group sold 13,221 Novavax shares in Q2 2021, an estimated $2.4M.
  • Strategic Wealth Management Group first reported a position in Novavax in Q2 2020 and held it in 4 quarters.
  • Strategic Wealth Management Group's Novavax position peaked at $2.4M in Q1 2021.
  • 407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on Strategic Wealth Management Group's 13F filing for Q2 2021, filed 13 Aug 2021.